Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients

Translational Research

Volumn 157, Issue 1, 2011, Pages 19-28

  Andjelkovic, Tijana ^a   Bankovic, Jasna ^a   Stojsic, Jelena ^b   Milinkovic, Vedrana ^a   Podolski Renic, Ana ^a   Ruzdijic, Sabera ^a   Tanic, Nikola ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

AP PCR; arbitrarily primed polymerase chain reaction; CI; confidence interval; FAK; focal adhesion kinase; LOH; loss of heterozygosity; methylation specific PCR; MSP; non small cell lung carcinoma; NSCLC; PAA; PCR SSCP; polyacrylamide; polymerase chain reaction single strand conformational polymorphism; WHO; World Health Organization

Indexed keywords

BISULFITE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; DNA METHYLATION; DNA SEQUENCE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

EID: 78650001417     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.09.004     Document Type: Article

References (45)

1. J.R. Molina, P. Yang, S.D. Cassivi, S.E. Schild, and A.A. Adjei Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship Mayo Clin Proc 83 2008 584 594
2. B.G. Campling, and W.S. el-Deiry Clinical implications of p53 mutations in lung cancer Methods Mol Med 75 2003 53 77
3. J. Li, C. Yen, and D. Liaw PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
4. A. Yokomizo, D.J. Tindall, and H. Drabkin PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers Oncogene 17 1998 475 479
5. J.C. Soria, H.Y. Lee, and J.I. Lee Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation Clin Cancer Res 8 2002 1178 1184
6. Y. Hosoya, A. Gemma, and M. Seike Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis Lung Cancer 25 1999 87 93
7. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
8. V. Stambolic, D. MacPherson, and D. Sas Regulation of PTEN transcription by p53 Mol Cell 8 2001 317 325
9. D.J. Freeman, A.G. Li, and G. Wei PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and independent mechanisms Cancer Cell 3 2003 117 130
10. Y. Li, F. Guessous, and S. Kwon PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations Cancer Res 68 2008 1723 1731
11. J.S. Kim, C. Lee, C.L. Bonifant, H. Ressom, and T. Waldman Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA Mol Cell Biol 27 2007 662 677
12. Z. Chen, L.C. Trotman, and D. Shaffer Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis Nature 436 2005 725 730
13. W.D. Travis, E. Brambilla, H.K. Müller-Hermelink, C.C. Harris, WHO classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart 2004 IARC Press Lyon, France
14. J. Bankovic, J. Stojsic, and D. Jovanovic Identification of genes associated with non-small-cell lung cancer promotion and progression Lung Cancer 67 2010 151 159
15. J. Sambrook, E.F. Fritch, and T. Maniatis Molecular cloning: a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
16. J. Markovic, J. Stojsic, S. Zunic, S. Ruzdijic, and N. Tanic Genomic instability in patients with non-small cell lung cancer assessed by the arbitrarily primed polymerase chain reaction Cancer Invest 26 2008 262 268
17. M. Orita, H. Iwahana, H. Kanazawa, K. Hayashi, and T. Sekiya Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms Proc Natl Acad Sci U S A 86 1989 2766 2770
18. T. Andjelkovic, M. Pesic, J. Bankovic, N. Tanic, I.D. Markovic, and S. Ruzdijic Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R) Cancer Biol Ther 7 2008 1024 1032
19. H.E. Feilotter, M.A. Nagai, A.H. Boag, C. Eng, and L.M. Mulligan Analysis of PTEN and the 10q23 region in primary prostate carcinomas Oncogene 16 1998 1743 1748
20. M. Hahn, I. Wieland, and O.N. Koufaki Genetic Alterations of the Tumor Suppressor Gene PTEN/MMAC1 in Human Brain Metastases Clin Cancer Res 5 1999 2431 2437
21. P.C. Galipeau, L.J. Prevo, C.A. Sanchez, G.M. Longton, and B.J. Reid Clonal expansion, and loss of heterozygosity at chromosomes 9p, and 17p in premalignant esophageal (Barrett's) tissue J Nat Cancer Inst 91 1999 2087 2095
22. B.J. Reid, L.J. Prevo, and P.C. Galipeau Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression Am J Gastroenterol 96 2001 2839 2848
23. J.G. Herman, J.R. Graff, S. Myöhänen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci U S A 93 1996 9821 9826
24. M.A. Zysman, W.B. Chapman, and B. Bapat Considerations when analyzing the methylation status of PTEN tumor suppressor gene Am J Pathol 160 2002 795 800
25. D. Carbone, I. Chiba, and T. Mitsudomi Polymorphism at codon 213 within the p53 gene Oncogene 6 1991 1691 1692
26. K. Kurose, K. Gilley, S. Matsumoto, P.H. Watson, X.P. Zhou, and C. Eng Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas Nat Genet 32 2002 355 357
27. S.A. Danielsen, G.E. Lind, and M. Bjørnslett Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status Hum Mutat 29 2008 E252 E262
28. T.H. Hu, C.C. Huang, and P.R. Lin Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma Cancer 97 2003 1929 1940
29. E. Oki, E. Tokunaga, and T. Nakamura Genetic mutual relationship between PTEN and p53 in gastric cancer Cancer Lett 227 2005 33 38
30. S. Zienolddiny, D. Ryberg, M.O. Arab, V. Skaug, and A. Haugen Loss of heterozygosity is related to p53 mutations and smoking in lung cancer Br J Cancer 84 2001 226 231
31. J.M. Tang, Q.Y. He, R.X. Guo, and X.J. Chang Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis Lung Cancer 51 2006 181 191
32. S.G. Guang, T. Ogura, and I. Sekine Association between p53 mutation and clinicopathological features of non-small cell lung cancer Jpn J Clin Oncol 27 1997 211 215
33. M. Tamura, J. Gu, K. Matsumoto, S. Aota, R. Parsons, and K.M. Yamada Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Science 280 1998 1614 1617
34. V.M. Golubovskaya, and W. Cance Focal adhesion kinase and p53 signal transduction pathways in cancer Front Biosci 15 2010 901 912
35. J. Liliental, S.Y. Moon, and R. Lesche Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases Curr Biol 10 2000 401 404
36. G. Gadéa, L. Lapasset, C. Gauthier-Rouvire, and P. Roux Regulation of Cdc42-mediated morphological effects: a novel function for p53 EMBO J 21 2002 2373 2382
37. H.B. Salvesen, N. MacDonald, and A. Ryan PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma Int J Cancer 91 2001 22 26
38. A. Goel, C.N. Arnold, and D. Niedzwiecki Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers Cancer Res 64 2004 3014 3021
39. Y. Yin, and W.H. Shen PTEN: a new guardian of the genome Oncogene 27 2008 5443 5453
40. I. Lazaro-Trueba, C. Arias, and A. Silva Double Bolt Regulation of Rad51 by p53 Cell Cycle 5 2006 1062 1065
41. K.R. Loeb, and L.A. Loeb Significance of multiple mutations in cancer Carcinogenesis 21 2000 379 385
42. A.M. Puzio-Kuter, M. Castillo-Martin, and C.W. Kinkade Inactivation of p53 and Pten promotes invasive bladder cancer Genes Dev 23 2009 675 680
43. L. Catasus, A. Gallardo, M. Cuatrecasas, and J. Prat Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis Mod Pathol 22 2009 522 529
44. Y. Ushio, K. Tada, and S. Shiraishi Correlation of molecular genetic analysis of P53, MDM2, P16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma Front Biosci 8 2003 e281 e288
45. S. Regina, J.B. Valentin, and S. Lachot Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN Clin Chem 55 2009 1834 1842